Results 71 to 80 of about 17,466 (107)

Impaired Whole-Blood Fibrinolysis is a Predictor of Mortality in Intensive Care Patients

open access: yesTH Open
Background Altered fibrinolysis is considered to play a crucial role in the development of coagulopathy in sepsis. However, routine laboratory tests for fibrinolysis are currently very limited, and the impact of fibrinolytic capacity on ...
Julie S. Brewer   +3 more
doaj   +1 more source

Thrombosis in systemic lupus erythematosus: Role of impaired fibrinolysis

open access: yes, 2013
Systemic lupus erythematosus (SLE) is a chronic inflammatory autoimmune disease that can affect any part of the body, including the skin, liver, kidneys, and blood.
Dhillon, P (15815948)   +1 more
core   +1 more source

Neutrophil extracellular traps formation is associated with impaired clot retraction and fibrinolysis in asthma

open access: yesFrontiers in Immunology
BackgroundAsthma is associated with an elevated risk of venous thromboembolism and pulmonary embolism; its etiology is not completely understood.ObjectiveThis study was designed to investigate whether the formation of neutrophil extracellular traps (NET)
Tomasz Misztal   +5 more
doaj   +1 more source

The fibrinolytic response to acute resistance training in lean and obese women

open access: yes, 2007
Fibrinolysis is the process by which fibrin blood clots are dissolved. Fibrinolytic research is clinically relevant because decreased fibrinolytic potential is linked to increased risk of an ischemic event.
Pfeiffer, Rebecca L.
core  

Outcomes according to timely or delayed primary percutaneous coronary intervention or fibrinolysis in a national registry of patients with ST-segment elevation myocardial infarction

open access: yesOpen Heart
Background Time to reperfusion is a predictor of long-term outcomes in ST-segment elevation myocardial infarction (STEMI). Timely primary percutaneous coronary intervention (PCI) is the preferred strategy recommended by guidelines.
Peter Kearney   +14 more
doaj   +1 more source

Plasma thrombin activatable fibrinolysis inhibitor levels in Behcet's disease

open access: yes, 2007
Aim: The precise pathogenetic mechanisms causing thrombotic complications in Behcet's disease (BID) are still not known. To explain the pathogenesis with coagulation induction or a defective fibrinolysis superimposed on endothelial dysfunction, various ...
Akkoç, Nurullah   +11 more
core  

Successful treatment of massive pulmonary embolism with low-dose tissue plasminogen activator after meniscus surgery

open access: yes, 2018
Pulmonary embolism is a life-threatening disease which represents with high mortality and morbidity. Systemic fibrinolysis is the first-line recommended therapy in hemodynamically instable patients with massive pulmonary embolism.
Kalkan, Ali K.   +5 more
core   +1 more source

An antifibrinolytic effect associated with an anti-factor V antibody in a patient with severe thrombophilia

open access: yesHaematologica, 2003
BACKGROUND AND OBJECTIVES: The case of a patient with thrombotic manifestations and severe activated protein C resistance due to an anti-factor V antibody has recently been described.
M Colucci   +5 more
doaj  

Platelet protease nexin-1 limits fibrinolysis in patients with cirrhosis

open access: yesJHEP Reports
Background & Aims: The role of protease nexin 1 (PN-1), a serine protease inhibitor that regulates both coagulation and fibrinolysis, is unknown in patients with cirrhosis. This study aimed to provide a comprehensive assessment of the role of PN-1 in
Alix Riescher-Tuczkiewicz   +13 more
doaj   +1 more source

Studies on Intrinsic Fibrinolysis: Activation and Inhibition [PDF]

open access: yes
P(論文)The activation of coagulation Facor XII results in initiation of the intrinsic fibrinolysis. This study was carried out to clarify what promoting and inhibitory factors are related to the process.
23197, 佐藤, 雅寛男
core   +1 more source

Home - About - Disclaimer - Privacy